Literature DB >> 22175819

Hypothermia for neonatal encephalopathy: Nationwide Survey of Clinical Practice in Japan as of August 2010.

Osuke Iwata1, Makoto Nabetani, Toshiki Takenouchi, Takayuki Iwaibara, Sachiko Iwata, Masanori Tamura.   

Abstract

BACKGROUND: Therapeutic hypothermia is now recommended as a standard of care for neonatal encephalopathy. Although adherence to standard cooling protocols used in the phase-III trials is essential, empiric approaches have prevailed in Japan. AIM: To elucidate the gap between the standard cooling methods and the current practice in Japan.
METHOD: In July 2010, a questionnaire regarding the practice of neonatal encephalopathy was mailed to clinical leads of registered neonatal intensive care units. RESULT: 56.2% of the units were incapable of offering therapeutic hypothermia because of the reasons such as the shortage of human/medical resources (85.1%) and limited number of cases (21.1%). Eighty-nine centres provided therapeutic hypothermia using either selective-head cooling (88.8%) or whole-body cooling (11.2%). Various target temperatures and cooling durations were used; 20.2% of the units cooled infants without using purpose-built equipments, whereas 14.6% did not continuously monitor the body temperature. DISCUSSION: Only 43.8% of the units provided therapeutic hypothermia. Even in centres where hypothermia was offered, adherence to the standard protocols was extremely poor. To secure the safety and efficacy, further promotion of the standard cooling protocols is required; an efficient cooling centre network has to be established by optimizing the work forth distribution and transportation system.
© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.

Entities:  

Mesh:

Year:  2012        PMID: 22175819     DOI: 10.1111/j.1651-2227.2011.02562.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  The baby cooling project of Japan to implement evidence-based neonatal cooling.

Authors:  Osuke Iwata; Toshiki Takenouchi; Sachiko Iwata; Makoto Nabetani; Takeo Mukai; Jun Shibasaki; Kennosuke Tsuda; Takuya Tokuhisa; Hisanori Sobajima; Masanori Tamura
Journal:  Ther Hypothermia Temp Manag       Date:  2014-12       Impact factor: 1.286

2.  Three-year outcome following neonatal encephalopathy in a high-survival cohort.

Authors:  Kennosuke Tsuda; Jun Shibasaki; Tetsuya Isayama; Akihito Takeuchi; Takeo Mukai; Yuichiro Sugiyama; Tomoaki Ioroi; Akihito Takahashi; Nanae Yutaka; Sachiko Iwata; Makoto Nabetani; Osuke Iwata
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

3.  Temperature control during therapeutic hypothermia for newborn encephalopathy using different Blanketrol devices.

Authors:  Abbot R Laptook; Howard Kilbride; Edward Shepherd; Scott A McDonald; Seetha Shankaran; William Truog; Abhik Das; Rosemary D Higgins
Journal:  Ther Hypothermia Temp Manag       Date:  2014-12       Impact factor: 1.286

Review 4.  Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy.

Authors:  Makoto Nabetani; Haruo Shintaku; Takashi Hamazaki
Journal:  Pediatr Res       Date:  2017-11-08       Impact factor: 3.756

5.  Therapeutic hypothermia for neonatal encephalopathy: a report from the first 3 years of the Baby Cooling Registry of Japan.

Authors:  Kennosuke Tsuda; Takeo Mukai; Sachiko Iwata; Jun Shibasaki; Takuya Tokuhisa; Tomoaki Ioroi; Hiroyuki Sano; Nanae Yutaka; Akihito Takahashi; Akihito Takeuchi; Toshiki Takenouchi; Yuko Araki; Hisanori Sobajima; Masanori Tamura; Shigeharu Hosono; Makoto Nabetani; Osuke Iwata
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.